<!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd">
<head>
<meta http-equiv="default-style" content="text/html; charset=utf-8" />
<title>Campbell-Walsh-Wein Urology Twelfth Edition Review</title>
<link rel="stylesheet" type="text/css" href="../../style/Elsevier_eBook.css" />
<link rel="stylesheet" type="text/css" media="only screen" href="../../style/media.css" />
  

<link rel="stylesheet" type="text/css" href="../../widgets/common_assets/css/common.css" />
<link rel="stylesheet" type="text/css" href="../../widgets/common_assets/css/variables.css" />
<script type="text/javascript" src="../../widgets/common_assets/scripts/mathjax/tex-mml-chtml.js"></script>
<script type="text/javascript" src="../../widgets/common_assets/scripts/common.js"></script>
<script type="text/javascript" src="../../widgets/img_lightbox_handler/img_lightbox_data.js"></script>
<script type="text/javascript" src="../../widgets/img_lightbox_handler/img_lightbox_parent.js"></script>

</head>
<body>
<section epub:type="chapter">
<a id="c0151"></a>
<header>
<div id="CN">151</div>
<h1 class="chaptitle" epub:type="title" id="B9780323639699001518">Pathology of Prostatic Neoplasia</h1>
<address>
<div class="chapau" id="augrp0010">Jonathan I. Epstein</div>
</address>
</header>
<section>
<h3 class="h2hd" id="cesectitle0010">Keywords</h3>
<div class="keywords">Gleason grade; grade group; high-grade prostatic intraepithelial neoplasia; intraductal carcinoma; prostate adenocarcinoma</div>
</section>
<section>
<section>
    <div>
    <iframe src="../../widgets/MCMS/xhtml/ch151_assessments.xhtml" height="650"></iframe>

    <div class="pageavoid">
<figure class="fig" id="f0011">
<img src="../../IMAGES/B9780323639699001518/main.assets/f151-01-9780323639699.jpg" alt="image"/>
<figcaption class='figleg'>
<a id="cap0010"/>
<a id="fspara0010"/>
<span class="fignum">Fig. 151.1</span> (From Bostwick DG, Cheng L: <span class="italic">Urologic surgical pathology</span>, ed 2, Edinburgh, 2008, Mosby.)</figcaption>
</figure>
</div>

<div class="pageavoid">
<figure class="fig" id="f0016">
<img src="../../IMAGES/B9780323639699001518/main.assets/f151-02-9780323639699.jpg" alt="image"/>
<figcaption class='figleg'>
<a id="cap0015"/>
<a id="fspara0015"/>
<span class="fignum">Fig. 151.2</span> (From Bostwick DG, Cheng L: <span class="italic">Urologic surgical pathology</span>, ed 2, Edinburgh, 2008, Mosby.)</figcaption>
</figure>
</div>

    </div>
</section>
<section>

</section>
<section>
	<span id="s0010"></span><span id="s0015"></span><span id="s0020"></span>
<a id="s0025"></a>
<h2 class="h1hd" id="cesectitle0030">Pathology</h2>
<div id="p0305"></div>
<div>
<ul class="ce_list" id="olist0065">
<li class="numlist" id="p0310">
<a id="o0290"></a>1. <span class="bold">c. Follow up the patient with a PSA and DRE in 3 to 6 months.</span> The patient has BPH as demonstrated by the presence of a basal layer with the positive cytokeratin stain. Because of the abnormal DRE, close follow-up is indicated.</li>
<li class="numlist" id="p0315">
<a id="o0295"></a>2. <span class="bold">a. Ask the pathologist for a Gleason score and volume of cancer.</span> The figure demonstrates a straightforward Gleason 6 adenocarcinoma. The pathologist needs to report the Gleason score and the volume of cancer in the biopsy specimen for the physician to make an informed decision about management.</li>
</ul>
</div>
<div>

<div class="boxg1" id="b0010">
<p></p>
<div class="b1title" epub:type="title" id="title5050">Chapter Review</div>
<div id="bpar0010"></div>
<div>
<ul class="ce_list" id="olist0070">
<li class="b1numlist" id="bpar0015">
<a id="o0300"></a>1. PIN is classified into low and high grade.</li>
<li class="b1numlist" id="bpar0020">
<a id="o0305"></a>2. Low-grade PIN does not increase the risk of prostate cancer.</li>
<li class="b1numlist" id="bpar0025">
<a id="o0310"></a>3. Rebiopsying patients with PIN is unnecessary unless there are multiple cores involved with high-grade PIN or there are other clinical indications.</li>
<li class="b1numlist" id="bpar0030">
<a id="o0315"></a>4. Eighty-five percent of prostate adenocarcinomas are in the peripheral zone, and 85% are multifocal.</li>
<li class="b1numlist" id="bpar0035">
<a id="o0320"></a>5. Peripherally located cancers tend to extend outside the prostate through the perineural space. The presence of perineural invasion within the prostatectomy specimens does not worsen the prognosis. By contrast, vascular invasion increases the risk of metastatic disease.</li>
<li class="b1numlist" id="bpar0040">
<a id="o0325"></a>6. Prostate cancer metastasizes, in descending order, to lymph nodes, bone, lung, bladder, liver, and adrenal glands.</li>
<li class="b1numlist" id="bpar0045">
<a id="o0330"></a>7. Subdividing pathologic T2 disease has no prognostic significance.</li>
<li class="b1numlist" id="bpar0050">
<a id="o0335"></a>8. Transition zone tumors require larger volumes than peripheral zone tumors for comparable rates of extraprostatic extension and/or distant metastases.</li>
<li class="b1numlist" id="bpar0055">
<a id="o0340"></a>9. For needle biopsy specimens, the primary pattern (dominant pattern) and the highest grade (irrespective of volume) should be reported as the Gleason sum.</li>
<li class="b1numlista" id="bpar0060">
<a id="o0345"></a>10. Adverse findings on needle biopsy generally accurately predict adverse findings in radical prostatectomy specimens. However, favorable findings on needle biopsy do not necessarily predict favorable findings in the radical prostatectomy specimen.</li>
<li class="b1numlista" id="bpar0065">
<a id="o0350"></a>11. Benign glands are differentiated from malignant glands in that the former contain basal cells. These can be labeled, if necessary, with high-molecular-weight cytokeratin and p63. Patients with atypical glands reported on biopsy specimens have a high likelihood of cancer on rebiopsy. Follow-up is warranted with serum or urine tests, imaging, and, in some cases, repeat biopsy with relative increased sampling of the atypical site.</li>
<li class="b1numlista" id="bpar0070">
<a id="o0355"></a>12. Adenosis (atypical adenomatous hyperplasia) is characteristically found in the transition zone, and although it may mimic carcinoma histologically, there is no increased risk for adenocarcinoma in patients with this diagnosis.</li>
<li class="b1numlista" id="bpar0075">
<a id="o0360"></a>13. Only 25% of men with seminal vesicle invasion and few with lymph node metastases are biochemically free of disease following radical prostatectomy 10 years postoperatively.</li>
<li class="b1numlista" id="bpar0080">
<a id="o0365"></a>14. Tumor volume correlates well with pathologic stage and Gleason grade in clinical T2 cancers; however, it is not an independent predictor of cancer progression once grade, stage, and margins are accounted for.</li>
<li class="b1numlista" id="bpar0085">
<a id="o0370"></a>15. The prostate lacks a discrete histologic capsule.</li>
<li class="b1numlista" id="bpar0090">
<a id="o0375"></a>16. Involvement of the seminal vesicles is almost always due to direct extension (T3b); it carries a poor prognosis.</li>
<li class="b1numlista" id="bpar0095">
<a id="o0380"></a>17. Only 50% of men with positive margins progress following radical prostatectomy.</li>
<li class="b1numlista" id="bpar0100">
<a id="o0385"></a>18. Endocrine therapy results in atrophic changes with squamous metaplasia in the prostate. Carcinomas in patients who have had endocrine therapy may appear artifactually higher in grade.</li>
<li class="b1numlista" id="bpar0105">
<a id="o0390"></a>19. Primary urothelial carcinomas of the prostate show a propensity to infiltrate the bladder neck and surrounding tissue such that more than 50% of the patients are stage T3 or T4, and 20% have distant metastases at the time of presentation.</li>
<li class="b1numlista" id="bpar0110">
<a id="o0395"></a>20. Intraductal carcinoma is morphologically worse than high-grade PIN and is typically associated with high-grade carcinoma.</li>
</ul>
</div>
</div>
</div>
</section>
</section>
</section><span id="f0010"></span><span id="f0015"></span><span id="pagebreak_582"></span>
</body>
</html>
